Ranbaxy takes the lions share

 In Australia, NewZealand, Pharmacy
AFTER 15 weeks on the US market, Ranbaxy’s atorvastatin molecule leads the market with a share of 47{845d44a2f09c0018d802e19e78941a85dc2180e4ed7410cee0b34e8cb134ecea}, according to Morgan Stanley Research.

In second place is Pfizer with a share of 32{845d44a2f09c0018d802e19e78941a85dc2180e4ed7410cee0b34e8cb134ecea}, followed by Watson which takes third place with 21{845d44a2f09c0018d802e19e78941a85dc2180e4ed7410cee0b34e8cb134ecea} of the market. Pharmacy Daily – Read More.

Recent Posts

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.